Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8097
Title: Severe methemoglobinemia caused by prilocaine: A rare case report
Authors: Karabulut, Alpaslan
Sahin, Mustafa
Keywords: Cyanosis
methemoglobinemia
prilocaine
Issue Date: 2021
Publisher: International Journal of Medical Biochemistry
Series/Report no.: Case Report;205-207
Abstract: Hemoglobin is a molecule found in erythrocytes that transports oxygen to tissues. Methemoglobin, a form of hemoglobin that can no longer bind oxygen, is formed when the ferrous iron in normal hemoglobin becomes ferric iron as a result of oxidation due to various kinds of oxidative stress. Methemoglobinemia can be congenital, however, exposure to toxins is more often the cause. Local anesthetics can occasionally cause methemoglobinemia, and the potential effects increase with combined or excessive use. Prilocaine-induced methemoglobinemia has been reported, though it is rare. Presently described is the case of an adult case of methemoglobinemia, which developed following a prilocaine injection for fibromyalgia pain. Methylene blue treatment and adjuvant therapy resulted in recovery. This case report serves as a reminder that that prilocaine can be a cause of adult-acquired methemoglobinemia. Methylene blue treatment and adjuvant therapy consisting of infusions of 100% oxygen and 0.9% sodium chloride administered promptly can prevent potentially severe toxic effects.
URI: http://localhost:8080/xmlui/handle/123456789/8097
ISSN: 2618-642X
Appears in Collections:Vol 4 No 3 (2021)

Files in This Item:
File Description SizeFormat 
205-207.pdf1.39 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.